EU To Post Comments On Drug Sector Antitrust Probe

By Erin Coe

Law360, New York (February 03, 2009, 12:00 AM ET) -- The European Commission reportedly plans to disclose public comments it has received following its inquiry into whether major pharmaceutical companies have been involved in a scheme to delay or block the sale of generic versions of their drugs.

EU spokesman Jonathan Todd said Monday that the commission received more than 40 submissions during a consultation period that ended late last month and that they will be posted on the regulator’s Web site within the next few weeks, according to European news publication EurActiv.

The commission published...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles